All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Hodgkin's Disease Scholarly Journal

 Hodgkin lymphoma, otherwise called Hodgkin's lymphoma or Hodgkin's illness, is a kind of lymphoma, where malignancy starts from white platelets called lymphocytes. Biotherapy alternatives have developed for patients with B-ancestry Non-Hodgkins Lymphoma (NHL). A progression of novel mAbs with particularity for an assortment of surface antigens are right now under assessment. Rituximab utilized both for biotherapy of patients with B-heredity NHL who experience a repeat of their sickness after forefront treatment just as for bleeding edge treatment of B-ancestry NHL patients who are at high hazard to encounter a repeat after chemotherapy. Hodgkin Lymphoma (HL) shows a third month against TNF treatment which should be changed and seek after immunosuppressive treatment with hostile to TNF drugs, which were likewise utilized in the treatment of rheumatic sicknesses. A sort of periodical that incorporates unique examination articles composed by scientists and specialists in a specific scholastic control, giving a gathering to the creation and study of information.
Awards Nomination

Table of Contents